Pharmacoeconomic evaluation of schizophrenia in Taiwan: Model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs-Reference-Cited by-同舟云学术

Pharmacoeconomic evaluation of schizophrenia in Taiwan: Model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs

Published:2005-08 Issue:4 Volume:59 Page:385-394
ISSN:1323-1316
Container-title:Psychiatry and Clinical Neurosciences
language:en
Short-container-title:Psychiatry Clin Neurosci

Author:

YANG YEN KUANG,TARN YENG HUI,WANG TING YING,LIU CHIA-YIH,LAIO YI-CHENG,CHOU YUAN-HWA,LEE SHIN-MIN,CHEN CHUN-CHIH

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology,Neurology,General Medicine,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1819.2005.01390.x/fullpdf

Reference33 articles.

1. Direct and indirect costs of schizophrenia in community psychiatric services in Italy

2. Correlation between performance on the Continuous Performance Test and economic costs in patients with schizophrenia

3. The Economic Costs of Schizophrenia

4. Book Review: Residents Guide to the Treatment of People with Chronic Mental Illness

5. Costs of services for schizophrenic patients in Norway

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview and Use of Tools for Selecting Modelling Techniques in Health Economic Studies;PharmacoEconomics;2021-05-20

2. Systematic review of the methods of health economic models assessing antipsychotic medication for schizophrenia;PLOS ONE;2020-07-10

3. A Systematic Review of Economic Models Across the Entire Schizophrenia Pathway;PharmacoEconomics;2020-03-06

4. A systematic review of health economic models and utility estimation methods in schizophrenia;Expert Review of Pharmacoeconomics & Outcomes Research;2018-01-27

5. Systematic review of pharmacoeconomic models for schizophrenia;Journal of Market Access & Health Policy;2018-01